Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban for intracranial hemorrhage survivors with atrial fibrillation
2019-002075-33Phase 4Unknown
- Sponsor
- Hamilton Health Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of edoxaban in Atrial fibrillation (AFib) and intracerebral hemorrhage (ICH) (2 arms), sponsored by Hamilton Health Sciences. Status: unknown.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2019-002075-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002075-33.